4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0001788542-26-000007
Chief Commercial Officer sold 13,056 shares at an average $68.36 ($892,528)
From the SEC's structured data for this filing
Trades in this filing
Mottiwala Aziz · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-17 | Sale : show line 1 in the form | −4,286 | $69.42 | $297,534 | 70,250 | D |
| 2026-03-18 | Sale : show line 2 in the form | −4,330 | $68.71 | $297,514 | 65,920 | D |
| 2026-03-19 | Sale : show line 3 in the form | −4,440 | $67.00 | $297,480 | 61,480 | D |
| Open-market sales · 13,056 sh · avg $68.36 · $892,528 | ||||||
Loading xslF345X06/wk-form4_1773961455.xml…